Layla D. Berry

Array ( [id] => 16681753 [patent_doc_number] => 10941219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-09 [patent_title] => Method for refining sugammadex sodium [patent_app_type] => utility [patent_app_number] => 16/320492 [patent_app_country] => US [patent_app_date] => 2017-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3375 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17392433 [patent_doc_number] => 11241421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Combination therapies for treating cancer [patent_app_type] => utility [patent_app_number] => 16/318041 [patent_app_country] => US [patent_app_date] => 2017-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6072 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16475005 [patent_doc_number] => 10849925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-01 [patent_title] => Process for the preparation and purification of the sodium salt of hyaluronic acid [patent_app_type] => utility [patent_app_number] => 16/313409 [patent_app_country] => US [patent_app_date] => 2017-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7317 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14372343 [patent_doc_number] => 20190160084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => METHODS FOR THE TREATMENT OF CANCER USING MEGLUMINE [patent_app_type] => utility [patent_app_number] => 16/320725 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17742584 [patent_doc_number] => 11390641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => 5'S-LNA nucleotides and oligonucleotides [patent_app_type] => utility [patent_app_number] => 16/317586 [patent_app_country] => US [patent_app_date] => 2017-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5630 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14867957 [patent_doc_number] => 20190284220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => CRYSTAL FORM OF DAPAGLIFLOZIN INTERMEDIATE AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 16/317636 [patent_app_country] => US [patent_app_date] => 2017-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2899 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17028526 [patent_doc_number] => 11090324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-17 [patent_title] => Composition, for remedying female climacteric syndrome symptoms, comprising tectorigenin 7-O-Xylosylglucoside [patent_app_type] => utility [patent_app_number] => 16/491780 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3850 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12233146 [patent_doc_number] => 20180066009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'Nucleosides and Oligonucleotides for Studies on Reversal of Cytotoxic and Mutagenic Damage of DNA and as Diagnostics Tools' [patent_app_type] => utility [patent_app_number] => 15/648707 [patent_app_country] => US [patent_app_date] => 2017-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6584 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15193945 [patent_doc_number] => 10494451 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-03 [patent_title] => Chitosan-derivative compounds and methods of controlling microbial populations [patent_app_type] => utility [patent_app_number] => 15/648006 [patent_app_country] => US [patent_app_date] => 2017-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 61 [patent_no_of_words] => 21584 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14406947 [patent_doc_number] => 20190169317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => Unsaturated Derivatives of Polysaccharides, Method of Preparation Thereof and Use Thereof [patent_app_type] => utility [patent_app_number] => 16/311745 [patent_app_country] => US [patent_app_date] => 2017-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5385 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11977507 [patent_doc_number] => 20170281661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'USE OF SEDOHEPTULOSE FOR PREVENTION OR TREATMENT OF INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 15/622235 [patent_app_country] => US [patent_app_date] => 2017-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10471 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15622235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13915041 [patent_doc_number] => 10201616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-12 [patent_title] => Non-cleavable polymer conjugated with aVb3 integrin thyroid antagonists [patent_app_type] => utility [patent_app_number] => 15/616637 [patent_app_country] => US [patent_app_date] => 2017-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 75 [patent_no_of_words] => 11836 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14406751 [patent_doc_number] => 20190169219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => NEW CRYSTAL FORM OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR PROCESSES FOR PREPARATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/304280 [patent_app_country] => US [patent_app_date] => 2017-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12822 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13182135 [patent_doc_number] => 10106569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-23 [patent_title] => Inhibitors of sodium glucose transporter 1 for constipation [patent_app_type] => utility [patent_app_number] => 15/601175 [patent_app_country] => US [patent_app_date] => 2017-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 19653 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16405373 [patent_doc_number] => 10813909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-27 [patent_title] => Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer [patent_app_type] => utility [patent_app_number] => 16/302587 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 14522 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12724075 [patent_doc_number] => 20180133192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => Fructose analogs and their combinations as anti-cancer agents [patent_app_type] => utility [patent_app_number] => 15/591046 [patent_app_country] => US [patent_app_date] => 2017-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11935041 [patent_doc_number] => 20170239190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY' [patent_app_type] => utility [patent_app_number] => 15/588481 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15866 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12043502 [patent_doc_number] => 09821088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-11-21 [patent_title] => 'Compositions of carboxypolysaccharides and polyalkylene oxides ionically cross-linked using polyhydroxyl organic anions' [patent_app_type] => utility [patent_app_number] => 15/499112 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11901 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11992417 [patent_doc_number] => 20170296572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'Hydroxypropyl Beta-Cyclodextrin Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 15/499831 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 49413 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11921570 [patent_doc_number] => 09789131 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-10-17 [patent_title] => 'Compounds and methods for treating neurological and cardiovascular conditions' [patent_app_type] => utility [patent_app_number] => 15/494407 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 32442 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494407 [rel_patent_id] =>[rel_patent_doc_number] =>)